Smaller-scale trades involved Pacific Biosciences of California Inc (NASDAQ: PACB) and 10X Genomics Inc (NASDAQ: TXG ), with ARK purchasing 194,298 and 18,177 shares respectively, totaling $213,727 ...

Cathie Wood’s Ark Invest sold shares of Palantir Technologies on Tuesday, a trade worth $41.03 million, according to Benzinga ...

Tempus AI reassured investors that its major pharma contracts remain strong despite funding and tariff pressures.

On Tuesday, Cathie Wood ‘s Ark Invest made significant trades, notably selling shares of Palantir Technologies Inc. PLTR ...

The ARKK ETF also expanded its position in Natera Inc (NASDAQ: NTRA) by purchasing 55,623 shares, translating to an investment of around $8.75 million. This move suggests a growing interest in the ...

“Honoring the Past, Celebrating the Present and Embracing the Future” was the theme for the National Alliance on Mental ...

In 2014 Robin Greenwood and Andrei Shleifer, both of Harvard University, found that investors did not expect higher returns ...

Discussing Advanced Micro Devices, Inc. (AMD) stock on Schwab Network recently, Ryan Patel said that “if you believe in a ...

Detailed price information for Palantir Technologies Inc Cl A (PLTR-Q) from The Globe and Mail including charting and trades.

This column originally appeared in the WSJ’s Markets A.M. newsletter. You can sign up here to receive it in your inbox every ...

ARK Invest’s Cathie Wood says markets are shaking off major headwinds and may be primed for upside surprises—while warning ...

Shares of CRISPR Therapeutics (NASDAQ:CRSP) can’t seem to catch a break, now down close to 8% year to date and more than 80% ...